Pain Detection
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
BioTherapeutics IncVA - Blacksburg
2 programs2
pregabalin 300 mgPhase 11 trial
suzetrigine 100mgPhase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2024
2025
2026
BioTherapeutics Incsuzetrigine 100mg
BioTherapeutics Incpregabalin 300 mg
Clinical Trials (2)
Total enrollment: 40 patients across 2 trials
Pharmacodynamic Study of 100mg Suzegtrigine vs Placebo in Healthy Male Adults
Start: Jun 2025Est. completion: Jun 202520 patients
Phase 1Completed
Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults
Start: Oct 2024Est. completion: Oct 202420 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.